Login/Sign Up
₹10400
MRP ₹1040012% off
(Inclusive of all Taxes)
Get Free delivery (₹99)
Online payment accepted
Provide Delivery Location
Whats That
Selected Pack Size:30
(₹305.07 per unit)
Out of stock
(₹9152 per unit)
In Stock
Therapeutic Class
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Lorbriqua 100 mg Tablet contains the active substance Lorlatinib, which inhibits a type of enzyme called tyrosine kinase and triggers the death of cancer cells in patients with alterations in genes for ALK. Lorbriqua 100 mg Tablet is only given to patients whose disease is due to an alteration in the gene for ALK tyrosine kinase.
Lorlatinib belongs to the kinase inhibitor class of drugs. Lorlatinib is a drug used to treat a kind of non-small cell lung cancer (NSCLC) that has spread to other places of the body in adults. It works by preventing the malfunctioning protein from causing cancer cells to multiply.
Lorbriqua 100 mg Tablet should be stopped when a person faces a serious side effect that affects life quality. Otherwise, it would be best to keep taking Lorbriqua 100 mg Tablet until your doctor asks you to stop it.
Avoid smoking before starting the treatment while taking Lorbriqua 100 mg Tablet as smoking might alter the effectiveness of Lorbriqua 100 mg Tablet .
In elderly patients, the risk of side effects is greater. For the elderly, dose adjustment might be required, or your doctor might prescribe any other medication safe for the elderly.
You should complete the full course of Lorbriqua 100 mg Tablet as your doctor prescribes. After completing the full course of Lorbriqua 100 mg Tablet will work. It would help if you took Lorbriqua 100 mg Tablet at the right dose, right times and for the right number of days.
Detecting lung cancer in its early stages, when it is most treatable, is critical to survival. Early tumours have a cure rate of 85-90 per cent, but this depends on other factors.
Alcohol
Caution
It is not known if alcohol interacts with Lorbriqua 100 mg Tablet . However, as a precautionary measure, you are recommended not to consume alcohol with the Lorbriqua 100 mg Tablet to avoid unpleasant side effects.
Pregnancy
Unsafe
Lorbriqua 100 mg Tablet is listed as pregnancy category D. Because Lorbriqua 100 mg Tablet can cause harm to the fetus, women of childbearing potential should be advised to avoid becoming pregnant while receiving treatment with Lorbriqua 100 mg Tablet .
Breast Feeding
Unsafe
Do not breastfeed for seven days after the last dose while taking this medicine. This is because it is unknown if the Lorbriqua 100 mg Tablet can pass into breast milk and could harm your baby.
Driving
Caution
Lorbriqua 100 mg Tablet moderately influences the ability to drive and use machines. Caution should be exercised when driving or operating machines, as patients may experience CNS effects.
Liver
Caution
Inform your doctor before receiving the Lorbriqua 100 mg Tablet if you have a history of liver diseases/conditions. Your doctor may adjust your dose depending on your current liver conditions.
Kidney
Caution
Inform your doctor before receiving the Lorbriqua 100 mg Tablet if you have a history of kidney diseases/conditions. Your doctor may adjust your dose depending on your current kidney conditions.
Children
Unsafe
Lorbriqua 100 mg Tablet is only indicated in adults, and it is not to be given to children and adolescents.
Product Substitutes
About Lorbriqua 100 mg Tablet
Lorbriqua 100 mg Tablet belongs to the group of medicines that inhibit an enzyme called anaplastic lymphoma kinase (ALK). It is used to treat adults with advanced stages of lung cancer called non-small cell lung cancer (NSCLC). Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the lung tissues. There are several types of non-small cell lung cancer. Smoking is the major risk factor for non-small cell lung cancer.
Lorbriqua 100 mg Tablet contains the active substance Lorlatinib, a medicine used to treat adults with advanced stages of a form of lung cancer called non-small cell lung cancer (NSCLC). It works by inhibiting a type of enzyme called tyrosine kinase and triggers the death of cancer cells in patients with alterations in genes for ALK. Lorbriqua 100 mg Tablet is only given to patients whose disease is due to an alteration in the gene for ALK tyrosine kinase.
Always use this medicine as your doctor has told you or per the package leaflet. You must keep to your doctor's instructions to get the maximum benefit. In some cases, you may experience common side effects such as diarrhoea, constipation, joint pain, weight gain, headache, rash, and muscle pain. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Consult your doctor before taking Lorbriqua 100 mg Tablet if you are pregnant or breastfeeding. Lorbriqua 100 mg Tablet may cause tiredness and dizziness, so drive with caution. Avoid consuming alcohol with Lorbriqua 100 mg Tablet as it could lead to increased dizziness. Lorbriqua 100 mg Tablet is not recommended for children below 18 years as safety and effectiveness have not been established. Lorbriqua 100 mg Tablet is listed as pregnancy category D. Because Lorbriqua 100 mg Tablet can cause harm to the fetus, women of childbearing potential should be advised to avoid becoming pregnant while receiving treatment with Lorbriqua 100 mg Tablet . Consult your doctor if you are breastfeeding; your doctor will decide whether Lorbriqua 100 mg Tablet can be taken by breastfeeding mothers or not. Keep your doctor informed about your health condition and medicines to rule out any side effects. Lorbriqua 100 mg Tablet may affect male fertility. Talk to your doctor about fertility preservation before taking Lorbriqua 100 mg Tablet .
Uses of Lorbriqua 100 mg Tablet
Medicinal Benefits
Lorbriqua 100 mg Tablet contains the active substance Lorlatinib, a medicine used to treat adults with advanced stages of a form of lung cancer called non-small cell lung cancer (NSCLC). Lorbriqua 100 mg Tablet is only given to patients whose disease is due to an alteration in the gene for ALK tyrosine kinase. It works by inhibiting a type of enzyme called tyrosine kinase and triggers the death of cancer cells in patients with alterations in genes for ALK.
Directions for Use
Side Effects of Lorbriqua 100 mg Tablet
Drug Warnings
Consult your doctor before taking Lorbriqua 100 mg Tablet if you are pregnant or breastfeeding. Lorbriqua 100 mg Tablet may cause tiredness and dizziness, so drive with caution. Avoid consuming alcohol with Lorbriqua 100 mg Tablet as it could lead to increased dizziness. Lorbriqua 100 mg Tablet is not recommended for children below 18 years as safety and effectiveness have not been established. Lorbriqua 100 mg Tablet is listed as pregnancy category D. Because Lorbriqua 100 mg Tablet can cause harm to the fetus, women of childbearing potential should be advised to avoid becoming pregnant while receiving treatment with Lorbriqua 100 mg Tablet . Consult your doctor if you are breastfeeding; your doctor will decide whether the Lorbriqua 100 mg Tablet can be taken by breastfeeding mothers or not. Keep your doctor informed about your health condition and medicines to rule out any side effects. Lorbriqua 100 mg Tablet may affect male fertility. Talk to your doctor about fertility preservation before taking Lorbriqua 100 mg Tablet .
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
Login/Sign Up
Drug-Drug Interactions Checker List
Habit Forming
Special Advise
You will have blood tests before you start treatment and during your treatment. These tests check the level of cholesterol, triglycerides and the enzymes amylase or lipase in your blood before you start treatment with Lorbriqua 100 mg Tablet and regularly during treatment. You will have blood tests before you start treatment and during your treatment. These tests check the level of cholesterol, triglycerides and the enzymes amylase or lipase in your blood before you start treatment with Lorbriqua 100 mg Tablet and regularly during treatment.
Diet & Lifestyle Advise
Have a query?
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Natco Pharma Ltd
Dr Reddy's Laboratories Ltd
Cipla Ltd
Celon Laboratories Pvt Ltd
Sun Pharmaceutical Industries Ltd
Alkem Laboratories Ltd
United Biotech Pvt Ltd
Zydus Cadila
Zydus Healthcare Ltd
Neon Laboratories Ltd
Glenmark Pharmaceuticals Ltd
Mylan Pharmaceuticals Pvt Ltd
BDR Pharmaceuticals Internationals Pvt Ltd
Emcure Pharmaceuticals Ltd
Adley Formulations
Samarth Life Sciences Pvt Ltd
Hetero Drugs Ltd
Torrent Pharmaceuticals Ltd
Fresenius Kabi India Pvt Ltd
Pfizer Ltd
Admac Lifesciences(Oncology)
Adley Pharmaceuticals Ltd
Novartis India Ltd
Halsted Pharma Pvt Ltd
Getwell Life Sciences India Pvt Ltd
Lupin Ltd
Cadila Healthcare Ltd
Hetero Healthcare Pvt Ltd
GLS Pharma Ltd
Reliance Formulation Pvt Ltd
Abbott India Ltd
Aimcad Biotech Pvt Ltd
Astra Zeneca Pharma India Ltd
Therdose Pharma Pvt Ltd
Axiommax Oncology Pvt Ltd
Biochem Pharmaceutical Industries Ltd
Khandelwal Laboratories Pvt Ltd
Msn Laboratories Pvt Ltd
Aureate Healthcare
Caitlin Oncology
Dabur India Ltd
Zee Laboratories Ltd
Sarabhai Chemicals (India) Pvt Ltd
Wembrace Biopharma Pvt Ltd
Delarc Pharmaceuticals Pvt Ltd
Medaegis Biotek Pvt Ltd
Panacea Biotec Ltd
RPG Life Sciences Ltd
Shilpa Medicare Ltd
Getwell Oncology Pvt Ltd
Ipca Laboratories Ltd
Miracalus Pharma Pvt Ltd
Biocon Ltd
Cadila Pharmaceuticals Ltd
Eli Lilly and Company (India) Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Getwell Pharmaceutical Pvt Ltd
Maximal Healthcare Pvt Ltd
Boehringer Ingelheim India Pvt Ltd
Del Trade International Pvt Ltd
Sayre Therapeutics Pvt Ltd
Akumentis Healthcare Ltd
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Hilfen Pharmaceuticals Pvt Ltd
Johnson & Johnson Pvt Ltd
Mankind Pharma Pvt Ltd
Merck Ltd
Oncostar Pharma Pvt Ltd
Rhone Poulenc Rorer India Pvt Ltd
Vhb Life Sciences Inc
Zuventus Healthcare Ltd
Admac Pharma Ltd
Adonis Laboratories Pvt Ltd
Alniche Life Sciences Pvt Ltd
BPRL Pvt Ltd
Caitlin Life Care
Dr Care
German Remedies Ltd
Janssen Pharmaceuticals Pvt Ltd
MEDICAMEN BIOTECH LTD
Maxis Healthcare (I) Pvt Ltd
Pharm Products Pvt Ltd
Accord Life Spec Pvt Ltd
Amps Biotech Biotech Pvt Ltd
Aphia Healthcare
Astellas Pharma India Pvt Ltd
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Bharat Serums and Vaccines Ltd
Cellgen Biopharma
Cosmic Life Sciences
Daris Biocare
East West Pharma India Pvt Ltd
Hillrock Biotech Pvt Ltd
Lucien Life Sciences
Maneesh Pharmaceuticals Ltd
Medilief Bioscience Pvt Ltd